Encouraging First-in-Human Results for a Promising HIV Vaccine

Posted on June 6th, 2023 by Lawrence Tabak, D.D.S., Ph.D

In recent years, weve witnessed some truly inspiring progress in vaccine development. That includes themRNA vaccinesthat were so critical during the COVID-19 pandemic, the first approved vaccine forrespiratory syncytial virus (RSV), and a universal flu vaccine candidate that could one day help to thwart future outbreaks of more novelinfluenza viruses.

Inspiring progress also continues to be made toward a safe and effective vaccine for HIV, which still infects about 1.5 million people around the world each year [1]. A prime example is the recent first-in-human trial of an HIV vaccine made in the lab from a unique protein nanoparticle, a molecular construct measuring justa few billionths of a meter.

Read more...